![Sunil Agarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Agarwal
Director/Board Member at
Nesos, Inc.
Net worth: 94 676 $ as of 2026-06-29
Profile
Sunil Agarwal is on the board of Calithera Biosciences, Inc. and Nesos, Inc. and Chief Medical Officer, EVP & Head-Development at Sana Biotechnology, Inc. In his past career he was Chief Medical Officer & Executive Vice President at Ultragenyx Pharmaceutical, Inc., Partner at Sofinnova Investments, Inc., Principal at Guilford Co., President-Research & Development at Juno Therapeutics, Inc., Senior VP & Global Head-Clinical Development at Genentech, Inc., Principal at MedImmune LLC, Principal at Kosan Biosciences, Inc. and Assistant Clinical Professor at The GW School of Business. He received an undergraduate degree from Cornell University and a doctorate from Tufts University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC. 0.02% | 2026-03-30 | 11,393 ( 0.02% ) | 94 676 $ | 2026-06-29 |
Sunil Agarwal active positions
| Companies | Position | Start |
|---|---|---|
Nesos, Inc.
 Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Director/Board Member | - |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Director/Board Member | 2023-04-17 |
Norwest Venture Partners
 Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Private Equity Investor | 2024-09-30 |
Former positions of Sunil Agarwal
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | Director/Board Member | 2026-06-23 |
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 2026-01-22 |
| SANA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-04-09 |
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | 2022-12-31 |
| MYOKARDIA, INC. | Director/Board Member | 2020-11-16 |
Training of Sunil Agarwal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norwest Venture Partners
Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Finance |
Guilford Co.
 Guilford Co. Finance/Rental/LeasingFinance Guilford Co. is a private company based in VA. | Finance |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW School of Business
 The GW School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Nesos, Inc.
Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
Curie Bio Operations LLC
 Curie Bio Operations LLC Investment ManagersFinance Curie Bio invests in companies located in the United States. The firm targets companies operating in the fields of the biotech. It provides financing for seed stage capital requirements. | Finance |
- Stock Market
- Insiders
- Sunil Agarwal
